Sign in

or Register now

MyBreastCancerNetwork.com

See all of our health sites at www.HealthCentral.com
Tuesday, November, 24, 2009
  • Font size
Featured ContentPJ Hamel On NPR!

Reply to an Answer

In response to:
Hi: TPBM is short for a molecule of the chemical compound theophylline, 8-[(benzylthio)methyl]-(7CI,8CI). It was the subject of an interesting talk at yesterday's Endocrine Society conference in San Francisco. Apparently, it could be the base for the next generation of drugs that suppress ER-receptive breast cancer by inhibiting estrogen reception. Tamoxifen and aromatase inhibitors, currently being used to treat breast cancer, inhibit estrogen in two different ways; TPBM drugs could provide a third way. This is important, as breast cancer eventually becomes resistant to tamoxifen, and aromatase inhibitors come with lots of unpleasant side effects. Hope this helps you out- - PJH
Subject:
Comment:
Note: This Display Name will be publicly visible on your SharePosts, your profile on this site, and the rest of the Internet. To maintain your anonymity do not include personally identifiable information (such as your name or email address) in your Display Name, SharePosts, or any other public postings on our site.